TY - JOUR
T1 - Sinonasal malignancies in children
T2 - A 10-year, single-institutional review
AU - Zevallos, Jose P.
AU - Jain, Kunal S.
AU - Roberts, Dianna
AU - El-Naggar, Adel
AU - Hanna, Ehab Y.
AU - Kupferman, Michael E.
PY - 2011/9
Y1 - 2011/9
N2 - Objectives: Sinonasal malignancies in children are rare, histologically diverse tumors that present diagnostic and management challenges. The purpose of this study is to review the experience of a single cancer center in the management of pediatric sinonasal malignancies. Study Design: Retrospective review. Methods: Retrospective chart review. Results: Forty-four patients were identified. The median age was 12 years (range: 2-17), 54% were female, and the maxillary sinus was the most common primary site. Facial swelling and pain were the most common presenting complaints. Thirty-four patients (76%) in this series had paranasal sinus sarcomas, three patients had esthesioneuroblastomas, and eight patients had carcinomas. The 5-year overall survival, disease-specific survival, and recurrence rate for the entire group was 71%, 81%, and 43%, respectively. Conclusions: Pediatric sinonasal malignancies are rare, locally aggressive tumors associated with nonspecific signs and symptoms. Multimodality treatment can result in 5-year overall and disease-specific survival rates of over 70%. A multidisciplinary team approach is essential to optimize outcomes and limit the morbidity of treatment.
AB - Objectives: Sinonasal malignancies in children are rare, histologically diverse tumors that present diagnostic and management challenges. The purpose of this study is to review the experience of a single cancer center in the management of pediatric sinonasal malignancies. Study Design: Retrospective review. Methods: Retrospective chart review. Results: Forty-four patients were identified. The median age was 12 years (range: 2-17), 54% were female, and the maxillary sinus was the most common primary site. Facial swelling and pain were the most common presenting complaints. Thirty-four patients (76%) in this series had paranasal sinus sarcomas, three patients had esthesioneuroblastomas, and eight patients had carcinomas. The 5-year overall survival, disease-specific survival, and recurrence rate for the entire group was 71%, 81%, and 43%, respectively. Conclusions: Pediatric sinonasal malignancies are rare, locally aggressive tumors associated with nonspecific signs and symptoms. Multimodality treatment can result in 5-year overall and disease-specific survival rates of over 70%. A multidisciplinary team approach is essential to optimize outcomes and limit the morbidity of treatment.
KW - Pediatric sinonasal malignancies
UR - http://www.scopus.com/inward/record.url?scp=80052081594&partnerID=8YFLogxK
U2 - 10.1002/lary.21793
DO - 10.1002/lary.21793
M3 - Review article
C2 - 21739433
AN - SCOPUS:80052081594
SN - 0023-852X
VL - 121
SP - 2001
EP - 2003
JO - Laryngoscope
JF - Laryngoscope
IS - 9
ER -